Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is hepatotoxicity in patients treated with gemtuzumabozogamicin due to specific targeting of hepatocytes?

× No keyword cloud information.

9 in total

Review 1. Antibody Drug Conjugates: Preclinical Considerations.

Authors: Gadi G Bornstein
Journal: AAPS J Date: 2015-02-28 Impact factor: 4.009

Review 2. Building upon the success of CART19: chimeric antigen receptor T cells for hematologic malignancies.

Authors: Antonia Rotolo; Anastasios Karadimitris; Marco Ruella
Journal: Leuk Lymphoma Date: 2017-11-22

3. Liver Complications Following Treatment of Hematologic Malignancy With Anti-CD22-Calicheamicin (Inotuzumab Ozogamicin).

Authors: George B McDonald; James W Freston; James L Boyer; Laurie D DeLeve
Journal: Hepatology Date: 2019-01-18 Impact factor: 17.425

Review 4. Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia.

Authors: Daniel G Guy; Geoffrey L Uy
Journal: Curr Hematol Malig Rep Date: 2018-12 Impact factor: 3.952

5. Treatment of CD33-directed chimeric antigen receptor-modified T cells in one patient with relapsed and refractory acute myeloid leukemia.

Authors: Quan-shun Wang; Yao Wang; Hai-yan Lv; Qing-wang Han; Hui Fan; Bo Guo; Li-li Wang; Wei-dong Han
Journal: Mol Ther Date: 2014-09-01 Impact factor: 11.454

Review 6. Combining Biology and Chemistry for a New Take on Chemotherapy: Antibody-Drug Conjugates in Hematologic Malignancies.

Authors: Helen Ma; Ahmed Sawas
Journal: Curr Hematol Malig Rep Date: 2018-12 Impact factor: 3.952

Review 7. Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin.

Authors: Andrew J Cowan; George S Laszlo; Elihu H Estey; Roland B Walter
Journal: Front Biosci (Landmark Ed) Date: 2013-06-01

Review 8. Mechanisms contributing to ado-trastuzumab emtansine-induced toxicities: a gateway to better understanding of ADC-associated toxicities.

Authors: Yukinori Endo; Nishant Mohan; Milos Dokmanovic; Wen Jin Wu
Journal: Antib Ther Date: 2021-03-16

9. Gemtuzumab ozogamicin in children with relapsed or refractory acute myeloid leukemia: a report by Berlin-Frankfurt-Münster study group.

Authors: Naghmeh Niktoreh; Beate Lerius; Martin Zimmermann; Bernd Gruhn; Gabriele Escherich; Jean-Pierre Bourquin; Michael Dworzak; Lucie Sramkova; Claudia Rossig; Ursula Creutzig; Dirk Reinhardt; Mareike Rasche
Journal: Haematologica Date: 2018-08-09 Impact factor: 9.941

9 in total